These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29631553)

  • 1. Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa.
    Paslakis G; Maas S; Gebhardt B; Mayr A; Rauh M; Erim Y
    BMC Psychiatry; 2018 Apr; 18(1):93. PubMed ID: 29631553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.
    Misra M; Katzman DK; Estella NM; Eddy KT; Weigel T; Goldstein MA; Miller KK; Klibanski A
    J Clin Psychiatry; 2013 Aug; 74(8):e765-71. PubMed ID: 24021517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa.
    Gordon CM; Emans SJ; DuRant RH; Mantzoros C; Grace E; Harper GP; Majzoub JA
    Eat Weight Disord; 2000 Sep; 5(3):175-82. PubMed ID: 11082797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of leptin secretion with cognitive performance in patients with eating disorders.
    Wollenhaupt C; Wilke L; Erim Y; Rauh M; Steins-Loeber S; Paslakis G
    Psychiatry Res; 2019 Jun; 276():269-277. PubMed ID: 31125904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making.
    Paslakis G; Agüera Z; Granero R; Sánchez I; Riesco N; Jiménez-Murcia S; Fernández-García JC; Garrido-Sánchez L; Tinahones FJ; Casanueva FF; Baños RM; Botella C; Crujeiras AB; Torre R; Fernández-Real JM; Frühbeck G; Ortega FJ; Rodríguez A; Serra-Majem L; Fitó M; Menchón JM; Fernández-Aranda F
    Mol Cell Endocrinol; 2019 Nov; 497():110441. PubMed ID: 31121263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial.
    Fazeli PK; Lawson EA; Faje AT; Eddy KT; Lee H; Fiedorek FT; Breggia A; Gaal IM; DeSanti R; Klibanski A
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29325236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inpatient treatment for anorexia nervosa: a systematic review of randomized controlled trials.
    Suárez-Pinilla P; Peña-Pérez C; Arbaizar-Barrenechea B; Crespo-Facorro B; Del Barrio JA; Treasure J; Llorca-Díaz J
    J Psychiatr Pract; 2015 Jan; 21(1):49-59. PubMed ID: 25603451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexia nervosa: a unified neurological perspective.
    Hasan TF; Hasan H
    Int J Med Sci; 2011; 8(8):679-703. PubMed ID: 22135615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intranasal oxytocin on smoothie intake, cortisol and attentional bias in anorexia nervosa.
    Leppanen J; Cardi V; Ng KW; Paloyelis Y; Stein D; Tchanturia K; Treasure J
    Psychoneuroendocrinology; 2017 May; 79():167-174. PubMed ID: 28288443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index.
    Lawson EA; Eddy KT; Donoho D; Misra M; Miller KK; Meenaghan E; Lydecker J; Herzog D; Klibanski A
    Eur J Endocrinol; 2011 Feb; 164(2):253-61. PubMed ID: 21098684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.
    Dunlop BW; Rothbaum BO; Binder EB; Duncan E; Harvey PD; Jovanovic T; Kelley ME; Kinkead B; Kutner M; Iosifescu DV; Mathew SJ; Neylan TC; Kilts CD; Nemeroff CB; Mayberg HS
    Trials; 2014 Jun; 15():240. PubMed ID: 24950747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocrine manifestations of anorexia nervosa: mechanisms and management.
    Schorr M; Miller KK
    Nat Rev Endocrinol; 2017 Mar; 13(3):174-186. PubMed ID: 27811940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic and psychological factors related to the body mass index of patients with anorexia nervosa.
    Kawai K; Yamanaka T; Yamashita S; Gondo M; Morita C; Arimura C; Nozaki T; Takii M; Kubo C
    Eat Weight Disord; 2008 Dec; 13(4):198-204. PubMed ID: 19169076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.
    Gowers SG; Clark AF; Roberts C; Byford S; Barrett B; Griffiths A; Edwards V; Bryan C; Smethurst N; Rowlands L; Roots P
    Health Technol Assess; 2010 Mar; 14(15):1-98. PubMed ID: 20334748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine consequences of anorexia nervosa.
    Misra M; Klibanski A
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):581-92. PubMed ID: 24731664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of three psychological treatments for anorexia nervosa.
    Byrne S; Wade T; Hay P; Touyz S; Fairburn CG; Treasure J; Schmidt U; McIntosh V; Allen K; Fursland A; Crosby RD
    Psychol Med; 2017 Dec; 47(16):2823-2833. PubMed ID: 28552083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are psychotropic drugs necessary for the treatment of anorexia and bulimia nervosa?].
    Thiel A
    Psychother Psychosom Med Psychol; 1997; 47(9-10):332-45. PubMed ID: 9411463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen administration improves the trajectory of eating disorder pathology in oligo-amenorrheic athletes: A randomized controlled trial.
    Plessow F; Singhal V; Toth AT; Micali N; Eddy KT; Misra M
    Psychoneuroendocrinology; 2019 Apr; 102():273-280. PubMed ID: 30639922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.
    Hay PJ; Claudino AM; Touyz S; Abd Elbaky G
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD003909. PubMed ID: 26212713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
    Hagman J; Gralla J; Sigel E; Ellert S; Dodge M; Gardner R; O'Lonergan T; Frank G; Wamboldt MZ
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.